{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:20:17Z","timestamp":1789874417178,"version":"4.0.1"},"reference-count":50,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T00:00:00Z","timestamp":1331769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Blood safety warrants strict screening measures to minimize the risk of transmitting blood\u2010borne pathogens. However, transfusion\u2010transmitted infections for which testing is not currently performed continue to be a concern. Among these untested agents is Epstein\u2010Barr virus (EBV) which, in the transplant setting, is associated with lymphoproliferative disease, a potentially fatal cancer. The aim of this study was to analyze the incidence of posttransplant EBV infection and its association with administration of blood products in children receiving a hematopoietic stem cell (HSC) graft.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> This retrospective cohort study sought to review charts of pediatric recipients of HSC grafts to collect information on the presence of EBV antibodies in the recipients' pretransplant sera and in HSC donor sera, incidence of posttransplant EBV infection, and patients' transfusion history. Cumulative incidence of posttransplant EBV infection was estimated by Kaplan\u2010Meier methods according to pretransplant serology. The association between blood products and EBV infection was measured by Cox regression models.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> The pretransplant EBV seroprevalence was 77.9% for recipients and 61.8% for graft donors. Virtually, all recipients received blood products during the peritransplant period. Among seronegative recipients, the 30\u2010 and 60\u2010day cumulative incidences of posttransplant EBV infection were 4.6 (95% confidence interval [CI], 1.2\u201017.3) and 13.4% (95% CI, 5.8%\u201029.4%), respectively. The 60\u2010day cumulative incidence was 8.3% (95% CI, 2.2%\u201029.4%) when restricting the analysis to seronegative recipients of cord blood grafts. Importantly, there was a clear positive trend associating EBV infection to transfusion volume.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> This study suggests an association between transfusions and posttransplant EBV infection in HSC transplant recipients.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2012.03611.x","type":"journal-article","created":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T12:57:34Z","timestamp":1331816254000},"page":"2653-2663","source":"Crossref","is-referenced-by-count":32,"title":["Transfusion\u2010related Epstein\u2010Barr virus infection among stem cell transplant recipients: a retrospective cohort study in children"],"prefix":"10.1111","volume":"52","author":[{"given":"Helen","family":"Trottier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Buteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Robitaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,3,15]]},"reference":[{"key":"e_1_2_8_2_2","unstructured":"Hema\u2010Qu\u00e9bec.Safety measures in place. [cited 2011 May 24]. Available from: URL:http:\/\/www.hema\u2010quebec.qc.ca\/comprendre\/mesures\u2010de\u2010securite\/securite\u2010en\u2010place.en.html"},{"key":"e_1_2_8_3_2","unstructured":"Canadian Blood Services.Safety and testing. [cited 2011 May 3]. Available from: URL:http:\/\/www.bloodservices.ca\/CentreApps\/Internet\/UW_V502_MainEngine.nsf\/page\/Testing?OpenDocument"},{"key":"e_1_2_8_4_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1155\/2005\/857914","article-title":"Transfusion and risk of infection in Canada: update 2005","volume":"16","author":"Macdonald N","year":"2005","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0707.017731"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4914(02)02361-4"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2009.09.001"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.2010.01003.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.12.019"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000265914.16491.7d"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/522531"},{"key":"e_1_2_8_12_2","first-page":"89","article-title":"Epstein\u2010Barr virus infection in transplant recipients: summary of a workshop on surveillance, prevention and treatment","volume":"3","author":"Allen U","year":"2002","journal-title":"Can J Infect Dis"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.150"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/510854"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1157\/13098571"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197701202960302"},{"key":"e_1_2_8_17_2","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood.V84.3.972.972","article-title":"Increased levels of circulating Epstein\u2010Barr virus (EBV)\u2010infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid organ transplant recipients","volume":"84","author":"Riddler SA","year":"1994","journal-title":"Blood"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01685.x"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.1995.tb00219.x"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(69)91532-3"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197005072821904"},{"key":"e_1_2_8_22_2","first-page":"146","article-title":"Infectious mononucleosis in the older patient","volume":"53","author":"Carter JW","year":"1978","journal-title":"Mayo Clin Proc"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1983.23483276870.x"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-77-5-751"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(71)90260-9"},{"key":"e_1_2_8_26_2","first-page":"201","volume-title":"Infection, immunity and blood transfusion. Proceedings of the XVth Annual Scientific Sympoium of the American Red Cross","author":"Henle W","year":"1985"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1969.tb01499.x"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1970.tb02910.x"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540260348626"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.2.812.bloodjournal872812"},{"key":"e_1_2_8_31_2","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1128\/JVI.72.5.4352-4363.1998","article-title":"Epidemiology of infection with Epstein\u2010Barr virus types 1 and 2: lessons from the study of a T\u2010cell\u2010immunocompromised hemophilic cohort","volume":"72","author":"Yao QY","year":"1998","journal-title":"J Virol"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190210197"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704433"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39111160.x"},{"key":"e_1_2_8_35_2","volume-title":"Blood banking and transfusion medicine\u2014basic principles and practice","author":"Hillyer CD","year":"2007"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2004.09.005"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/156.2.273"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198804000-00011"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-144-37586"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702770"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04815.x"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3143"},{"key":"e_1_2_8_43_2","volume-title":"Handbook of pediatric transfusion medicine","author":"Hillyer CD","year":"2004"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.3.378"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198910193211604"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198309000-00012"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.2.520.520"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199103000-00005"},{"key":"e_1_2_8_49_2","first-page":"2208","article-title":"Risk of lymphoproliferative disorders after bone marrow transplantation: a multi\u2010institutional study","volume":"94","author":"Curtis RE","year":"1999","journal-title":"Blood"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-178046"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181dd6c0a"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2012.03611.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2012.03611.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T17:18:18Z","timestamp":1697303898000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2012.03611.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,15]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/j.1537-2995.2012.03611.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2012.03611.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,15]]}}}